Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.

Phase 4

Completed

• Conditions: Pain
• Interventions: Drug: Marcaine; Drug: Chloroprocaine

• Registration Number: NCT02049255
• Lead Sponsor: Astes

Brief Summary

Comparison the use of marcaine and chloroprocaine in rachianesthesia for a surgical correction of inguinal hernia. Comparision between acute and chronic (3 months and 6 months) pain.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-11
• Study First Submitted: 2014-01-24
• Study First Submitted QC: 2014-01-29
• Study First Posted: 2014-01-30
• Status Verified: 2014-10
• Primary Completion: 2014-10
• Study Completion: 2014-10
• Last Update Submitted: 2014-10-31
• Last Update Posted: 2014-11-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Adults under rachianesthesia

Exclusion Criteria

• Personal history of gastric ulcus
• ASA 4
• Emergency
• Combined surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Marcaine	Marcaine	Rachianesthesia with marcaine or chloroprocaine
Chloroprocaine	Chloroprocaine	Rachianesthesia with marcaine or chloroprocaine

Primary Outcome Measures

Name	Time	Method
Acute pain	1 day of the surgery when patient leave the recovery room

Secondary Outcome Measures

Name	Time	Method
Chronic pain	at 3 and 6 months

Trial Locations

Locations (1)

Clinique Saint-Luc Bouge; 🇧🇪 Bouge, Namur, Belgium